UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 15.205

Sortiert nach

S885 Factors Associated With Crohn’s Disease Progression Events in the IBD PLEXUS and IQVIA Linked Dataset

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S659-S660

2023

Link zum Volltext

Verfügbarkeit prüfen

Children's Rates of BMI Change Prepandemic and During Two COVID‐19 Pandemic Periods, IQVIA AEMR, January 2018‐November 2021

Obesity (Silver Spring, Md.), 2022-11

2022

Link zum Volltext

Verfügbarkeit prüfen

S1053 Characteristics, Medication and Healthcare Utilization of Crohn’s Disease Patients Stratified by Short-CDAI Status: Descriptive Results From the IBD PLEXUS and IQVIA Linked Dataset

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e763-e764

2022

Link zum Volltext

Verfügbarkeit prüfen

Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?: A Validation Study Based on Prescribing Codeine in Children

Clinical pharmacology and therapeutics, 2020-04, Vol.107 (4), p.915-925

2020

Link zum Volltext

Verfügbarkeit prüfen

EE625 Time in Range As Alternative to HBA1C Change in the IQVIA Core Diabetes Model

Value in health, 2023-12, Vol.26 (12), p.S173

2023

Link zum Volltext

Verfügbarkeit prüfen

EE319 Update to the Macrovascular Submodels of the IQVIA Core Diabetes Model

Value in health, 2023-12, Vol.26 (12), p.S112

2023

Link zum Volltext

Verfügbarkeit prüfen

EE470 Comparing Three Indirect Cost Approaches in the IQVIA Core Diabetes Model

Value in health, 2023-12, Vol.26 (12), p.S142

2023

Link zum Volltext

Verfügbarkeit prüfen

EPH172 Real-World Trends of Patients with Syphilis in Japan Using Integrated Data of IQVIA Claims, Jast Data and Desc Database

Value in health, 2023-06, Vol.26 (6), p.S195-S195

2023

Link zum Volltext

Verfügbarkeit prüfen

EE649 Contrasting 4 Different Mortality Predictions in Patients With Type 1 Diabetes Using the IQVIA Core Diabetes Model

Value in health, 2022-12, Vol.25 (12), p.S184-S184

2022

Link zum Volltext

Verfügbarkeit prüfen

EPH173 Real Picture of Patients with Charcot-Marie-Tooth Disease in Japan: IQVIA Claims Database

Value in health, 2022-07, Vol.25 (7), p.S466

2022

Link zum Volltext

Verfügbarkeit prüfen

EE262 Contrasting Four Type 2 Diabetes Cardiovascular Risk Equations for East Asia Using the IQVIA Core Diabetes Model

Value in health, 2022-07, Vol.25 (7), p.S385

2022

Link zum Volltext

Verfügbarkeit prüfen

EE366 Contrasting Three HbA1c Progression Equations Using the IQVIA Core Diabetes Model

Value in health, 2022-07, Vol.25 (7), p.S407

2022

Link zum Volltext

Verfügbarkeit prüfen

Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?

Clinical pharmacology and therapeutics, 2020-04, Vol.107 (4), p.915-925

2020

Link zum Volltext

Verfügbarkeit prüfen

Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide

Journal of medical economics, 2023, Vol.26 (1), p.1019-1031

2023

Link zum Volltext

Verfügbarkeit prüfen

Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)

Cardiology and therapy, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

PDB44 DOES INCLUDING ACUTE PANCREATITIS AS A COMPLICATION HAVE AN IMPACT ON COST-EFFECTIVENESS ANALYSES USING THE IQVIA CORE DIABETES MODEL?

Value in health, 2020-05, Vol.23, p.S116-S116

2020

Link zum Volltext

Verfügbarkeit prüfen

PDB52 IMPACT OF USING DIFFERENT TYPES OF HBA1C PROGRESSION IN THE IQVIA CORE DIABETES MODEL

Value in health, 2020-05, Vol.23, p.S117-S118

2020

Link zum Volltext

Verfügbarkeit prüfen

PDB56 CONTRASTING THREE TYPE 2 DIABETES CARDIOVASCULAR RISK EQUATIONS FOR EAST ASIA WITH UKPDS82 USING THE IQVIA CORE DIABETES MODEL

Value in health, 2020-05, Vol.23, p.S118-S118

2020

Link zum Volltext

Verfügbarkeit prüfen

PDB61 THE CLINICAL AND ECONOMIC IMPACT OF ADDING AN ADHERENCE MODULE TO THE IQVIA CORE DIABETES MODEL

Value in health, 2019-11, Vol.22, p.S584-S584

2019

Link zum Volltext

Verfügbarkeit prüfen

PDB17 HEALTH ECONOMIC EFFECTS OF THE UPDATED FOOT ULCER SUBMODEL IN THE IQVIA CORE DIABETES MODEL

Value in health, 2019-11, Vol.22, p.S575-S575

2019

Link zum Volltext

Verfügbarkeit prüfen

IQVision: An Image-Based Evaluation Tool for Quantitative Lateral Flow Immunoassay Kits

Biosensors (Basel), 2021-06, Vol.11 (7), p.211

2021

Link zum Volltext

Verfügbarkeit prüfen

Generic, Biosimilar Drugs Generate Record Savings of $373 Billion in 2021: But Many Patients Pay More Than Necessary Because of PBMs, Patent Abuses, IQVIA Data Show

Pharmacy times, 2022-12, Vol.88 (12), p.40

Hunter, Erin

2022

Link zum Volltext

Verfügbarkeit prüfen

PDB26 CONTRASTING THREE TYPE 2 DIABETES CARDIOVASCULAR RISK EQUATIONS FOR EAST ASIA WITH UKPDS82 USING THE IQVIA CORE DIABETES MODEL

Value in health, 2019-05, Vol.22, p.S144-S144

2019

Link zum Volltext

Verfügbarkeit prüfen

PDB35 CONTRASTING FRAMINGHAM RISK EQUATIONS IN TYPE 2 DIABETES USING THE IQVIA CORE DIABETES MODEL

Value in health, 2019-05, Vol.22, p.S145-S145

2019

Link zum Volltext

Verfügbarkeit prüfen

PDB64 ASSOCIATION BETWEEN CARDIOVASCULAR DISEASE RISK FACTORS AND HYPOGLYCAEMIC EVENTS IN TYPE 2 DIABETES USING THE IQVIA CORE DIABETES MODEL

Value in health, 2019-05, Vol.22, p.S151-S151

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 15.205

Suche als RSS-Feed

Aktive Filter

PublikationsformReferenzeintrag

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.793)
Mit Volltextzugriff
(7.088)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

14 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Nexis Uni
(6.602)
Factiva
(4.941)
EZB Free E-Journals
(3.289)
Ingenta
(1.894)
Journals@Ovid Complete
(1.354)
ProQuest Dissertations & Theses A&I
(1.225)
IngentaConnect Journals
(1.067)
EBSCOhost Business Source Ultimate
(970)
Springer Nature - Complete Springer Journals
(954)
Single Online Journals
(906)
Wiley Online Library Journals Frontfile Complete
(663)
Jstor Complete Legacy
(401)
Ebook Central Perpetual and DDA
(390)
eBooks on EBSCOhost
(386)
Wiley Online Library
(348)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(342)
Elsevier ScienceDirect Journals Complete
(324)
SAGE Complete
(245)
Taylor & Francis Current Content Access
(244)
Taylor & Francis Online
(220)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Pr Newswire
(1.710)
Business Wire
(1.138)
M2 Presswire
(707)
Business World
(135)
Pharmaceutical Executive
(110)
The Gentleman's Magazine: And Historical Chronicle, Jan. 1736-Dec. 1833
(101)
Chain Drug Review
(99)
Blood
(90)
Pharmacy Times
(87)
Pharmacoeconomics & Outcomes News
(81)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

S885 Factors Associated With Crohn’s Disease Progression Events in the IBD PLEXUS and IQVIA Linked Dataset

Children's Rates of BMI Change Prepandemic and During Two COVID‐19 Pandemic Periods, IQVIA AEMR, January 2018‐November 2021

S1053 Characteristics, Medication and Healthcare Utilization of Crohn’s Disease Patients Stratified by Short-CDAI Status: Descriptive Results From the IBD PLEXUS and IQVIA Linked Dataset

Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?: A Validation Study Based on Prescribing Codeine in Children

EE625 Time in Range As Alternative to HBA1C Change in the IQVIA Core Diabetes Model

EE319 Update to the Macrovascular Submodels of the IQVIA Core Diabetes Model

EE470 Comparing Three Indirect Cost Approaches in the IQVIA Core Diabetes Model

EPH172 Real-World Trends of Patients with Syphilis in Japan Using Integrated Data of IQVIA Claims, Jast Data and Desc Database

EE649 Contrasting 4 Different Mortality Predictions in Patients With Type 1 Diabetes Using the IQVIA Core Diabetes Model

EPH173 Real Picture of Patients with Charcot-Marie-Tooth Disease in Japan: IQVIA Claims Database

EE262 Contrasting Four Type 2 Diabetes Cardiovascular Risk Equations for East Asia Using the IQVIA Core Diabetes Model

EE366 Contrasting Three HbA1c Progression Equations Using the IQVIA Core Diabetes Model

Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?

Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide

Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)

PDB44 DOES INCLUDING ACUTE PANCREATITIS AS A COMPLICATION HAVE AN IMPACT ON COST-EFFECTIVENESS ANALYSES USING THE IQVIA CORE DIABETES MODEL?

PDB52 IMPACT OF USING DIFFERENT TYPES OF HBA1C PROGRESSION IN THE IQVIA CORE DIABETES MODEL

PDB56 CONTRASTING THREE TYPE 2 DIABETES CARDIOVASCULAR RISK EQUATIONS FOR EAST ASIA WITH UKPDS82 USING THE IQVIA CORE DIABETES MODEL

PDB61 THE CLINICAL AND ECONOMIC IMPACT OF ADDING AN ADHERENCE MODULE TO THE IQVIA CORE DIABETES MODEL

PDB17 HEALTH ECONOMIC EFFECTS OF THE UPDATED FOOT ULCER SUBMODEL IN THE IQVIA CORE DIABETES MODEL

IQVision: An Image-Based Evaluation Tool for Quantitative Lateral Flow Immunoassay Kits

Generic, Biosimilar Drugs Generate Record Savings of $373 Billion in 2021: But Many Patients Pay More Than Necessary Because of PBMs, Patent Abuses, IQVIA Data Show

PDB26 CONTRASTING THREE TYPE 2 DIABETES CARDIOVASCULAR RISK EQUATIONS FOR EAST ASIA WITH UKPDS82 USING THE IQVIA CORE DIABETES MODEL

PDB35 CONTRASTING FRAMINGHAM RISK EQUATIONS IN TYPE 2 DIABETES USING THE IQVIA CORE DIABETES MODEL

PDB64 ASSOCIATION BETWEEN CARDIOVASCULAR DISEASE RISK FACTORS AND HYPOGLYCAEMIC EVENTS IN TYPE 2 DIABETES USING THE IQVIA CORE DIABETES MODEL

Aktive Filter

Suchergebnisse filtern